<a id='1cf59096-1059-49b9-ad0f-2544296852f7'></a>

References

<a id='c4702ef1-ebf1-4e64-9c46-013b911f3fbc'></a>

1) Omegaven [Prescribing Information] (Revised: 07/2018). Fresenius Kabi. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/0210589s000lbledt.pdf.
2) Fat Emulsion (Fish Oil Based). Lexi-Drugs. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com. Accessed August 7, 2018.
3) Fell, G. L., Nandivada, P., Gura, K. M., & Puder, M. (2015). Intravenous Lipid Emulsions in Parenteral Nutrition—. Advances in Nutrition, 6(5), 600-610.
4) Yang, C. F. J., Lee, M., Valim, C., Hull, M. A., Zhou, J., Jones, B. A., ... & Jaksic, T. (2009). Persistent alanine aminotransferase elevations in children with parenteral nutrition-associated liver disease. Journal of pediatric surgery, 44(6), 1084-1088.
5) Puder, M., Valim, C., Meisel, J. A., Le, H. D., De Meijer, V. E., Robinson, E. M., ... & Gura, K. M. (2009). Parenteral fish oil improves outcomes in patients with parenteral nutrition associated liver injury. Annals of surgery, 250(3), 395.
6) Diamond, I. R., Sterescu, A., Pencharz, P. B., Kim, J. H., & Wales, P. W. (2009). Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. Journal of pediatric gastroenterology and nutrition, 48(2), 209-215.
7) Park, K. T., Nespor, C., & Kerner Jr, J. (2011). The use of Omegaven in treating parenteral nutrition-associated liver disease. Journal of Perinatology, 31(S1), S57.
8) Premkumar, M. H., Carter, B. A., Hawthorne, K. M., King, K., & Abrams, S. A. (2013). High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy. The Journal of pediatrics, 162(4), 793-798.
9) Nandivada, P., Chang, M. I., Potemkin, A. K., Carlson, S. J., Cowan, E., O'loughlin, A. A., ... & Puder, M. (2015). The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy. Annals of surgery, 261(1), 172.
10) Intralipid® 20% [prescribing information] Baxter Healthcare Corporation. http://ecatalog.baxter.com/ecatalog/loadResource.blob?bid=20000307.
11) Smoflipid [prescribing information] Fresenius Kabi. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207648lbl.pdf.
12) Appropriate Dosing for Parenteral Nutrition: ASPEN Recommendations. ASPEN. 2019. https://nutritotal.com.br/pro/wp-content/uploads/sites/3/2019/04/PN-DosingASPEN.pdf
13) Mesotten, Dieter, et al. "ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: carbohydrates." Clinical Nutrition 37.6 (2018): 2337-2343.
14) Cober, M. Patrea. Strategies for Successful Parenteral Nutrition Order Writing. ASHP Midyear 2016. https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Clinical-Pharmacy-Resources/Nutrition-Support/2016-MCM/MCM16-335-Strategies-for-Successful-Parenteral-nutrition.ashx?la=en&hash=2E203D2D4AB34E3A9831B780B0FD7285280E84BC

<a id='346d76bd-7321-47f3-8e4b-db05226456bc'></a>

CAPTION ERROR

<a id='34c748a7-9b04-4deb-a661-8b05f53c3354'></a>

<::logo: Stanford Medicine
Stanford Medicine
A maroon shield with a caduceus and other symbols is positioned to the left of the text "Stanford Medicine", which is split by a vertical line.::>

<a id='9b02f3db-6f33-44c0-b779-32de210ff16f'></a>

Appendix

<a id='33eacae8-5753-460f-be92-91895fe65446'></a>

<::logo: Stanford Children's Health / Lucile Packard Children's Hospital Stanford
Stanford Children's Health; Lucile Packard Children's Hospital Stanford
A red rectangular logo featuring a white stylized shield with a child and adult figure, alongside white text.::>

<a id='f9641fae-f471-4028-a2fd-410637a33828'></a>

<::Stanford Medicine logo:
Visual: Stanford shield emblem.
Text: Stanford | MEDICINE::>

<a id='bd0923fe-097a-4940-8932-58fd56770a99'></a>

ASPEN Recommendations

<a id='8281407a-b3e4-4111-b081-ddc8af83a355'></a>

• Initiation and advancement of macronutrients

<a id='7ea2701d-f8eb-4426-a1f5-ad4eabc6293d'></a>

<table id="2-1">
<tr><td id="2-2" rowspan="2">Infants (<1 y)</td><td id="2-3" colspan="2">Initiation</td><td id="2-4" colspan="2">Advance By</td><td id="2-5" colspan="2">Goals</td></tr>
<tr><td id="2-6">Preterm</td><td id="2-7">Term</td><td id="2-8">Preterm</td><td id="2-9">Term</td><td id="2-a">Preterm</td><td id="2-b">Term</td></tr>
<tr><td id="2-c">Protein (g/kg/d)*</td><td id="2-d">1-3 (3-4 max)</td><td id="2-e">2.5-3</td><td id="2-f">—</td><td id="2-g">—</td><td id="2-h">3-4</td><td id="2-i">2.5-3</td></tr>
<tr><td id="2-j">Dextrose (mg/kg/min)</td><td id="2-k">6-8</td><td id="2-l">6-8</td><td id="2-m">1-2</td><td id="2-n">1-2</td><td id="2-o">10-14 (max 14-18)</td><td id="2-p">10-14 (max 14-18)</td></tr>
<tr><td id="2-q">ILE (g/kg/d)**</td><td id="2-r">0.5-1</td><td id="2-s">0.5-1</td><td id="2-t">0.5-1</td><td id="2-u">0.5-1</td><td id="2-v">3 (max 0.15 g/kg/h)</td><td id="2-w">2.5-3 (max 0.15 g/kg/h)</td></tr>
<tr><td id="2-x" colspan="7">Children (1–10 y)</td></tr>
<tr><td id="2-y">Protein (g/kg/d)</td><td id="2-z" colspan="2">1.5-2.5</td><td id="2-A" colspan="2">horizontal line</td><td id="2-B" colspan="2">1.5-2.5</td></tr>
<tr><td id="2-C">Dextrose (mg/kg/min)</td><td id="2-D" colspan="2">3-6</td><td id="2-E" colspan="2">1-2</td><td id="2-F" colspan="2">8-10</td></tr>
<tr><td id="2-G">ILE (g/kg/d)**</td><td id="2-H" colspan="2">1-2</td><td id="2-I" colspan="2">0.5-1</td><td id="2-J" colspan="2">2-2.5</td></tr>
<tr><td id="2-K" colspan="7">Adolescents</td></tr>
<tr><td id="2-L">Protein (g/kg/d)</td><td id="2-M" colspan="2">0.8-2</td><td id="2-N" colspan="2">horizontal line</td><td id="2-O" colspan="2">0.8-2</td></tr>
<tr><td id="2-P">Dextrose (mg/kg/min)</td><td id="2-Q" colspan="2">2.5-3</td><td id="2-R" colspan="2">1-2</td><td id="2-S" colspan="2">5-6</td></tr>
<tr><td id="2-T">ILE (g/kg/d)**</td><td id="2-U" colspan="2">1</td><td id="2-V" colspan="2">1</td><td id="2-W" colspan="2">1-2</td></tr>
</table>
*Protein does not need to be titrated; protein needs are increased with critical illness.
** ILE dosing based on soybean oil-based emulsion. See manufacturer's product information for dosing of other
ILE products.
ILE= Lipid injectable emulsion

<a id='9be7428f-c499-442e-ae0d-e6b9d29a94b9'></a>

<::logo: Stanford Children's Health / Lucile Packard Children's Hospital Stanford
Stanford Children's Health
Lucile Packard Children's Hospital Stanford
A red shield-shaped emblem featuring a white stylized figure of a person with outstretched arms.::>

<a id='b9d88fdb-ae97-40ff-bfd2-7cd5d1dcd166'></a>

<::logo: Stanford Medicine
Stanford Medicine
A red crest featuring a caduceus-like symbol is positioned to the left of the text "Stanford Medicine", which is separated by a vertical line.::>

<a id='e000c6a9-215b-40ec-b27a-e821b9f388ab'></a>

ASPEN Recommendations

<a id='11809926-a131-43d1-aecb-de070a96b0b0'></a>

* Electrolyte and minerals

<a id='44d56494-3900-4a7e-a796-91ddb280ed2a'></a>

<table id="3-1">
<tr><td id="3-2"></td><td id="3-3">Preterm Neonates</td><td id="3-4">Infants/Children</td><td id="3-5">Adolescents & Children Greater than 50 kg</td></tr>
<tr><td id="3-6">Sodium</td><td id="3-7">2-5 mEq/kg</td><td id="3-8">2-5 mEq/kg</td><td id="3-9">1-2 mEq/kg</td></tr>
<tr><td id="3-a">Potassium</td><td id="3-b">2-4 mEq/kg</td><td id="3-c">2-4 mEq/kg</td><td id="3-d">1-2 mEq/kg</td></tr>
<tr><td id="3-e">Calcium</td><td id="3-f">2-4 mEq/kg</td><td id="3-g">0.5-4 mEq/kg</td><td id="3-h">10-20 mEq</td></tr>
<tr><td id="3-i">Phosphorus</td><td id="3-j">1-2 mmol/kg</td><td id="3-k">0.5-2 mmol/kg</td><td id="3-l">10-40 mmol</td></tr>
<tr><td id="3-m">Magnesium</td><td id="3-n">0.3-0.5 mEq/kg</td><td id="3-o">0.3-0.5 mEq/kg</td><td id="3-p">10-30 mEq</td></tr>
<tr><td id="3-q">Acetate</td><td id="3-r" colspan="3">As needed to maintain acid base-balance</td></tr>
<tr><td id="3-s">Chloride</td><td id="3-t" colspan="3">As needed to maintain acid base-balance</td></tr>
</table>
*Use caution in prescribing calcium and phosphorus related to compatibility.

<a id='bfce2cb3-bc23-4187-8aa1-e2e6803415c9'></a>

Stanford
Children's Health

Lucile Packard
Children's Hospital
Stanford

<a id='26690e8b-5ffe-4eda-bb30-0cb819060322'></a>

<::logo: Stanford Medicine
Stanford MEDICINE
A maroon shield-like emblem with a caduceus symbol and a stylized tree, next to the word "Stanford" in maroon, separated by a vertical line from "MEDICINE" in black.::>

<a id='a59972c3-2bde-4a53-9d14-2eedc794a5b9'></a>

ASPEN Recommendations

<a id='a1bc697e-dee7-4504-b860-3d67869a8194'></a>

- Trace elements

<a id='b51b639a-8274-4172-9999-0ea61130c35c'></a>

<table id="4-1">
<tr><td id="4-2">Trace Element</td><td id="4-3">Preterm Neonates</td><td id="4-4">Term Neonates 3-10 kg</td><td id="4-5">Children 10-40 kg</td><td id="4-6">Adolescents Greater than 40 kg</td></tr>
<tr><td id="4-7">Zinc</td><td id="4-8">400 mcg/kg</td><td id="4-9">250 mcg/kg</td><td id="4-a">50 mcg/kg (max 5000 mcg/d)</td><td id="4-b">2-5 mg</td></tr>
<tr><td id="4-c">Copper</td><td id="4-d">20 mcg/kg</td><td id="4-e">20 mcg/kg</td><td id="4-f">20 mcg/kg (max 500 mcg/d)</td><td id="4-g">200-500 mcg</td></tr>
<tr><td id="4-h">Manganese</td><td id="4-i">1 mcg/kg</td><td id="4-j">1 mcg/kg</td><td id="4-k">1 mcg/kg (max 55 mcg/d)</td><td id="4-l">40-100 mcg</td></tr>
<tr><td id="4-m">Chromium</td><td id="4-n">0.05-0.3 mcg/kg</td><td id="4-o">0.2 mcg/kg</td><td id="4-p">0.2 mcg/kg (max 5 mcg/d)</td><td id="4-q">5-15 mcg</td></tr>
<tr><td id="4-r">Selenium</td><td id="4-s">2 mcg/kg</td><td id="4-t">2 mcg/kg</td><td id="4-u">2 mcg/kg (max 100 mcg/d)</td><td id="4-v">40-60 mcg</td></tr>
</table>
*Note: These requirements are different than the multi-trace element products currently available in the US.

<a id='6263dbcf-946f-49db-bab3-f0cfd7c91d62'></a>

CAPTION ERROR

<a id='98bc1969-98c1-4b57-a25b-c8d5648d4588'></a>

<::logo: Stanford Medicine
Stanford Medicine
A red shield with white intricate symbols is placed to the left of the text "Stanford Medicine", where "Stanford" is red and "Medicine" is black, separated by a red vertical line.::>

<a id='3efaa9a4-1d09-4626-82d7-4a0f6f4c02a2'></a>

IVFE Comparison

<a id='0550add5-25b6-42c4-b0b3-3d93d78db27b'></a>

Table 1. Comparison of 3 IV Fat Emulsions (IVFE)*
<table id="5-1">
<tr><td id="5-2"></td><td id="5-3">IntraLipid</td><td id="5-4">SMOFlipid</td><td id="5-5">Omegaven</td></tr>
<tr><td id="5-6"></td><td id="5-7" colspan="3">Percent</td></tr>
<tr><td id="5-8">Soybean oil</td><td id="5-9">100</td><td id="5-a">30</td><td id="5-b">0</td></tr>
<tr><td id="5-c">Medium chain triglyceride</td><td id="5-d">0</td><td id="5-e">30</td><td id="5-f">0</td></tr>
<tr><td id="5-g">Olive oil</td><td id="5-h">0</td><td id="5-i">25</td><td id="5-j">0</td></tr>
<tr><td id="5-k">Fish oil</td><td id="5-l">0</td><td id="5-m">15</td><td id="5-n">100</td></tr>
<tr><td id="5-o"></td><td id="5-p"></td><td id="5-q"></td><td id="5-r"></td></tr>
<tr><td id="5-s"></td><td id="5-t" colspan="3">Percent</td></tr>
<tr><td id="5-u">Linoleic acid (n-6)</td><td id="5-v">50</td><td id="5-w">21.4</td><td id="5-x">4.4</td></tr>
<tr><td id="5-y">Alpha-linolenic acid (n-3)</td><td id="5-z">9</td><td id="5-A">2.5</td><td id="5-B">1.8</td></tr>
<tr><td id="5-C">DHA (n-3)</td><td id="5-D">0</td><td id="5-E">2</td><td id="5-F">12.1</td></tr>
<tr><td id="5-G">EPA (n-3)</td><td id="5-H">0</td><td id="5-I">3</td><td id="5-J">19.2</td></tr>
<tr><td id="5-K"></td><td id="5-L"></td><td id="5-M"></td><td id="5-N"></td></tr>
<tr><td id="5-O"></td><td id="5-P" colspan="3">mg/Lt</td></tr>
<tr><td id="5-Q">Phytosterols</td><td id="5-R">348 ±33</td><td id="5-S">47.6</td><td id="5-T">0</td></tr>
<tr><td id="5-U">Alpha-tocopherol (Vitamin E)</td><td id="5-V">38</td><td id="5-W">200</td><td id="5-X">150-296</td></tr>
</table>

<a id='827c701d-803c-401b-82e0-3f137fe1530c'></a>

DHA is docosahexaenoic acid and EPA is eicosapentaenoic acid.
*Adapted from Anez-Bustillos et al. 20171
+Raman et al. 20172

<a id='68a26674-a9c2-4321-bf67-79a5e87f0935'></a>

<::logo: Stanford Children's Health / Lucile Packard Children's Hospital Stanford
Stanford Children's Health
Lucile Packard Children's Hospital Stanford
A red shield-like emblem with a stylized figure inside, accompanied by text in red and gray.::>

<a id='ca365561-189f-46a1-bee0-a753a18f2e16'></a>

<::logo: Stanford Medicine
Stanford MEDICINE
A dark red shield with a caduceus and a tree symbol, followed by "Stanford" in dark red, a vertical dark line, and "MEDICINE" in dark gray.::>

<a id='85ef626b-b101-4313-80ef-aae99e9c1ffd'></a>

LPCH Parenteral Nutrition

*   Current AA concentration limitations via central line PN at LPCH:
    *   <20 kg: AA 3.6%
    *   20-35 kg: AA 4.2%
    *   >35 kg: AA 5.2%

*   Origin of AA concentration limitations unclear

<a id='120d51d8-c776-4567-a1cb-18317018dec6'></a>

CAPTION ERROR

<a id='9bd4f1a7-93a5-4223-b4a3-4635b67d79aa'></a>

<::logo: Stanford Medicine
Stanford MEDICINE
A maroon shield with a white caduceus and tree symbol is positioned to the left of the words "Stanford" in maroon and "MEDICINE" in black, separated by a vertical maroon line.::>

<a id='d1d1d687-ddfc-4cf5-b884-33eb72bfd9d9'></a>

ASPEN 2014 Guidelines

<a id='27c8041c-dc02-4150-82af-83abf849fa2a'></a>

* Recommendations for 3-in-1 PN to optimize stability for up to 30 hours at room temperature:
  * AA ≥4%
  * Dextrose ≥10%
  * Lipids ≥2%
* Currently no guidance on the maximum allowable protein concentration

<a id='6e85029b-6cd1-44a6-bfa3-1db2fa0e55a8'></a>

CAPTION ERROR

<a id='7efe77d9-1da7-4620-b0c1-ddde2196d548'></a>

<::logo: Stanford Medicine
Stanford MEDICINE
A maroon shield with a white caduceus and tree symbol, next to the words "Stanford" in maroon and "MEDICINE" in black, separated by a vertical maroon line.::>

<a id='4fdd599a-8aac-4125-ab67-c78981e39de1'></a>

# Concerns and Considerations

* Macronutrient extremes (high or low) may compromise stability of the PN solution
* Higher viscosity of the admixture has unknown effect on the risk of line occlusions
* Institution-specific guidance on medication compatibility with parenteral nutrition may be affected by changes in allowable AA concentrations
* Impact on the non-protein calorie to nitrogen ratio (NPC:N)

<a id='774fa1ee-fb62-442b-a75e-d7052ce063b3'></a>

CAPTION ERROR

<a id='7dd1894b-c9f8-4370-8ada-acd34434aa2b'></a>

<::logo: Stanford Medicine
Stanford MEDICINE
A maroon shield with a white caduceus and tree symbol is positioned to the left of the words "Stanford" in maroon and "MEDICINE" in black, separated by a vertical maroon line.::>

<a id='7f76cea2-81ec-4193-8c6a-69665d9e5d93'></a>

Amino Acid Over-Provision

<a id='cfc4d6a6-fe26-4141-b31f-a2b6059d8872'></a>

*   **Possible complications of AA over-provision**
    *   Metabolic acidosis
        *   Cationic L-amino acid metabolism that produces H+ ions (excess acids that base reserves cannot neutralize)
        *   Oxidation of sulfur-containing AA

<a id='5f90b3b7-3669-46d5-a1b0-81a3e1e809bf'></a>

- Azotemia:
  * Proteins generate ammonia exceeding the urea cycle's capacity
  * Higher rates of urea synthesis in critically-ill patients
  * Renal blood flow/functional mass may have greater influence on plasma urea concentrations than rate of provision

<a id='f6dcb286-22be-4451-a2c7-4cb1617fa202'></a>

<::logo: Stanford Children's Health, Lucile Packard Children's Hospital Stanford
Stanford Children's Health
Lucile Packard Children's Hospital Stanford
A red shield emblem with a stylized figure inside, accompanied by text in dark gray and red, separated by a vertical line.::>

<a id='2d568192-5e26-43da-87ca-e5b13ce3bf3b'></a>

<::logo: Stanford Medicine
Stanford MEDICINE
A dark red shield emblem featuring a caduceus symbol and other stylized elements is positioned to the left of the text "Stanford" in dark red and "MEDICINE" in dark gray, separated by a vertical line.::>

<a id='fcc8201d-785b-4d40-bd37-8e759ac748a8'></a>

# Nitrogen Balance

*   **Non-protein calorie to nitrogen ratio (NPC:N)**
    *   <u>Ideal NPC:N ratio</u>
        *   Stable patients → 150-250:1
        *   Critically-ill patients → Optimal ratio may be less (e.g. 100:1)
        *   Renal failure patients → Optimal ratio may be higher
    *   <u>Monitoring</u>: Elevated BUN cannot be explained by changes in renal function, medications, bleeding or dehydration
*   **Amino acid intake to avoid negative nitrogen balance**
    *   <u>ESPGHAN/ESPEN/ESPR 2018 Guidelines</u>
        *   Stable term infants: Minimum AA 1.5 g/kg/d (max: 3.0 g/kg/d)

<a id='0e19efa8-4eef-4b90-9016-fefcb9549262'></a>

<::logo: Stanford Children's Health / Lucile Packard Children's Hospital Stanford
Stanford Children's Health
Lucile Packard Children's Hospital Stanford
A red shield-like emblem with a stylized figure inside, accompanied by text in red and gray.::>

<a id='20a9bca1-6fcc-4f92-9341-b6809216fdef'></a>

<::logo: Stanford Medicine
Stanford Medicine
A red crest featuring a caduceus-like symbol is positioned to the left of the text "Stanford Medicine", which is separated by a vertical line.::>

<a id='7d6ff6c1-d29a-4de9-92b7-fac6a1de2be7'></a>

## Lipids and Hyperinsulinemia

*   FFAs drive hepatic lipid synthesis and activate hepatic gluconeogenesis → hepatic glucose production

<a id='7077a826-d32c-42ea-a560-19c042b6c880'></a>

<::The image is a complex diagram illustrating the mechanisms of insulin resistance in different tissues: hepatic (liver), skeletal muscle, and white adipose tissue. The overall title of the diagram is "Hepatic insulin resistance".

**1. Skeletal Muscle Insulin resistance (left side):**
- A pink, muscle-shaped area is labeled "Skeletal Muscle Insulin resistance".
- Glucose uptake (via GLUT4) is shown to be decreased (down arrow).
- Glycogen synthesis is also decreased (down arrow).
- An insulin signaling pathway is depicted, where insulin normally promotes glucose uptake and glycogen synthesis, but in insulin resistance, this pathway is impaired, indicated by a blocked line from an insulin receptor-like structure to the glucose uptake and glycogen synthesis processes.
- An 'A' points to "Glucose turnover" which is connected to GLUT2.

**2. Hepatic insulin resistance (central, large liver shape):**
- A large, orange, liver-shaped area is labeled "Hepatic insulin resistance".
- **Insulin Signaling:**
  - Insulin binds to IR (Insulin Receptor), which activates IRS (Insulin Receptor Substrate).
  - IRS activates AKT.
  - AKT normally inhibits FOXO1, but this inhibition is impaired in insulin resistance.
  - AKT normally promotes Glycogen synthesis (via GS), but this is shown with a dashed line and a down arrow for "Glycogen synthesis", indicating decreased activity.
- **Glucose Metabolism:**
  - Glucose enters the liver via GLUT2.
  - Glycogen synthesis (via GS) is decreased (down arrow).
  - Glucogen (glycogen breakdown) is increased (up arrow).
  - Glycolysis (Glucose to Pyruvate) is shown, regulated by CHREB.
  - Pyruvate can be converted to Glucose via Gluconeogenesis, which is increased (up arrow). This process is regulated by PEPCK and G6Pase, which are activated by FOXO1. A 'C' points to "Gluconeogenesis".
  - Pyruvate can also be converted to AC-CoA via PC (Pyruvate Carboxylase).
  - AC-CoA leads to β-oxidation (increased, up arrow) and SREBP1c.
  - β-oxidation produces TGA (Triglycerides), indicated by multiple "TGA" labels with up arrows.
  - Glucose exits the liver via GLUT2, leading to increased "Hepatic glucose production" (up arrow).
- **Lipid Metabolism:**
  - SREBP1c leads to increased FA-CoA (up arrow).
  - FA-CoA is converted to DAG (Diacylglycerol) via MAGT (Monoacylglycerol acyltransferase).
  - DAG is converted to TGA (Triglycerides) via DAGT (Diacylglycerol acyltransferase).
  - TGA can be packaged into VLDL.
  - Increased FFAs (Free Fatty Acids) are shown (up arrow).
  - A feedback loop 'D' shows DAG activating PKCε (Protein Kinase C epsilon), which then inhibits IRS, contributing to insulin resistance.

**3. White Adipose Tissue Insulin resistance (bottom right):**
- A yellow, adipose tissue-shaped area is labeled "White Adipose Tissue Insulin resistance".
- Lipolysis is increased (up arrow).
- Increased lipolysis leads to increased FFAs (up arrow) and Glycerol (up arrow).
- A 'B' indicates that FFAs and Glycerol from adipose tissue feed into the liver, contributing to hepatic processes.

**Key symbols used:**
- Up arrow (↑): Increase
- Down arrow (↓): Decrease
- Blocked line (T-bar): Inhibition
- Dashed line: Impaired or indirect effect
- Solid line: Direct effect/conversion
: diagram::>

<a id='aee13845-04f4-4ee6-91fd-3699d3324121'></a>

CAPTION ERROR

<a id='7f5db586-05ed-4b85-b3f9-a9b022802d92'></a>

<::logo: Stanford Medicine
Stanford Medicine
The logo features a dark red shield with various symbols to the left of the words "Stanford" in dark red and "Medicine" in dark gray, separated by a vertical line.::>

<a id='75bc878a-ef9b-48c4-ac44-2397cd4fae83'></a>

Fluid Volumes

<a id='648a0f65-aae1-4087-b9c0-acb6a6211a25'></a>

<table id="12-1">
<tr><td id="12-2" colspan="3">Typical Fluids (mL/kg/day)</td></tr>
<tr><td id="12-3">Weight</td><td id="12-4">Initial Fluids</td><td id="12-5">Fluid Advance</td></tr>
<tr><td id="12-6">>1500 gm</td><td id="12-7">60-80</td><td id="12-8" rowspan="3">Over next 5 days if able (generally 10-20 mL/kg/day to goal 150-160 mL/kg/day)</td></tr>
<tr><td id="12-9">1000-1500 gm</td><td id="12-a">80</td></tr>
<tr><td id="12-b"><1000 gm</td><td id="12-c">80-100</td></tr>
</table>

<a id='0d74e9c2-bdbe-4a2f-9d75-a7fa7228b72f'></a>

<table id="12-d">
<tr><td id="12-e" colspan="2">Adjustment Considerations</td></tr>
<tr><td id="12-f">Increased Fluids</td><td id="12-g">Decreased Fluids</td></tr>
<tr><td id="12-h">• Excessive weight loss • Gastroschisis/ omphalocele • Immature skin • Polyuria, hypernatremia, hyperkalemia</td><td id="12-i">• Asphyxia/ cerebral edema • Generalized edema • Oliguria (SIADH, renal failure) • CHF or PDA</td></tr>
</table>

<a id='b0e05490-42fb-493c-81ad-88d1b8dc2ef1'></a>

<::logo: Lucile Packard Children's Hospital Stanford
Lucile Packard Children's Hospital Stanford
A red shield-like emblem with a stylized white figure of a child, next to gray and red text.::>

<a id='8d5d1da2-e938-474a-ac19-deaaa36002a1'></a>

<::logo: Stanford Medicine
Stanford MEDICINE
A maroon shield-like emblem with a caduceus symbol and a stylized tree, next to the word "Stanford" in maroon, separated by a vertical line from "MEDICINE" in black.::>

<a id='18b8ecd1-2c74-42d8-862c-e37c64bba5e4'></a>

# Total Body Water

* Measuring Total Body Water (TBW) is challenging
* Acute changes in weight indicate changes in TBW

<a id='0c065646-e9b6-4ae9-bf0f-02d1add2a58d'></a>

<table id="13-1">
<tr><td id="13-2">Age</td><td id="13-3">Percentage of TBW</td></tr>
<tr><td id="13-4">Fetus</td><td id="13-5">90%</td></tr>
<tr><td id="13-6">Premature Infant</td><td id="13-7">80%</td></tr>
<tr><td id="13-8">Term Infant</td><td id="13-9">70-75%</td></tr>
<tr><td id="13-a">Young Children</td><td id="13-b">65-70%</td></tr>
<tr><td id="13-c">Adolescent Children</td><td id="13-d">60%</td></tr>
<tr><td id="13-e">Adults</td><td id="13-f">50-60%</td></tr>
</table>

<a id='b0e8e4f4-b3e2-466f-82e1-83dcc948c311'></a>

CAPTION ERROR

<a id='62a5e71b-19c4-4011-bfec-dfc75e234990'></a>

<::logo: Stanford Medicine
Stanford Medicine
A red crest featuring a caduceus-like symbol is positioned to the left of the text "Stanford Medicine", which is separated by a vertical line.::>

<a id='68f64cbd-4f8b-4ed3-8410-2c545386fdd3'></a>

# Electrolytes- Sodium (Na)

*   Serum Osmolality- Water Homeostasis
*   Osm (serum)= (2xserum Na) + (serum glucose/18) + (BUN/2.8)
*   Regulated by urinary concentration and dilution (ADH) and thirst
*   Normal sodium requirement: 2-5 mEq/kg/day

<a id='e4775175-3d03-4e7c-b3f9-26a7fd0b5f25'></a>

<::flowchart
: The flowchart illustrates the regulation of plasma osmolality.

**Central Node:** Plasma osmolality (normal 280-290 mosmol/kg water)

**Path 1: Decreased Plasma Osmolality**
1. Plasma osmolality: Decreased
2. Leads to: Suppression of thirst and ADH release
3. Results in: Dilute urine
4. Ultimately leads to: Hyponatraemia

**Path 2: Increased Plasma Osmolality**
1. Plasma osmolality: Increased
2. Leads to two parallel effects:
   a. Stimulation of thirst and ADH release
   b. Stimulation of ADH release
3. Both lead to: Concentrated urine
4. Ultimately leads to: Hypernatraemia
: flowchart::>

<a id='55a2df2f-a504-48f2-8086-41cda56e93df'></a>

CAPTION ERROR

<a id='21ca6d27-0fd7-4b2e-9f9a-638825342b65'></a>

<::logo: Stanford Medicine
Stanford Medicine
A red crest featuring a caduceus-like symbol is positioned to the left of the text "Stanford Medicine", which is separated by a vertical line.::>

<a id='d8847bc3-dd70-4794-8c14-fa1d5c512c0b'></a>

# Hyponatremia

*   Serum Na <120
*   CNS Symptoms
    *   Lethargy
    *   Seizures
    *   Coma
    *   Death

Tal
Tyl
Dil
Hy
Eu

<a id='1de6b9af-7cf0-401c-b152-2b660bf8f5f5'></a>

<table id="15-1">
<tr><td id="15-2" colspan="3">Table 1. Classification of Hyponatremia2,8,30</td></tr>
<tr><td id="15-3">Type</td><td id="15-4">Characteristics</td><td id="15-5">Common Causes</td></tr>
<tr><td id="15-6" colspan="3">Dilutional hyponatremia</td></tr>
<tr><td id="15-7">Hypervolemic</td><td id="15-8">• Body water: increased
• Body sodium: increased
• Extracellular fluid: significantly increased
• Edema</td><td id="15-9">• Congestive heart failure
• Cirrhosis
• Nephrotic syndrome
• Acute kidney insufficiency
• Chronic renal failure</td></tr>
<tr><td id="15-a">Euvolemic</td><td id="15-b">• Body water: increased
• Body sodium: not increased
• Extracellular fluid: increased
• No edema</td><td id="15-c">• SIADH
• Glucocorticoid deficiency
• Thiazide diuretics
• Oral hypoglycemic drugs</td></tr>
<tr><td id="15-d" colspan="3">Depletional hyponatremia</td></tr>
<tr><td id="15-e">Hypovolemic</td><td id="15-f">• Body water: slightly decreased • Body sodium: decreased • Extracellular fluid: decreased • No edema</td><td id="15-g">• Diuretics • Salt-wasting nephropathy Mineralocorticoid deficiency • Diarrhea • Vomiting • Pancreatitis</td></tr>
<tr><td id="15-h" colspan="3">SIADH = syndrome of inappropriate antidiuretic hormone</td></tr>
</table>

<a id='f249f418-d7c8-480f-a45e-bcda45f25ac6'></a>

<table><thead><tr><th colspan="2">Depletional hyponatremia</th></tr></thead><tbody><tr><td>Hypovolemic</td><td>• Bc</td></tr></tbody></table>

<a id='fcd87ad3-101d-4434-95c2-c0e5cd63d380'></a>

CAPTION ERROR

<a id='a228ec36-8924-4969-9df9-8a99e3397bb7'></a>

CAPTION ERROR

<a id='f3b41361-8227-4bb5-9619-0c58c91994e8'></a>

Hypochloremia
* Diuretic use in our neonates often leads to low chloride levels (metabolic/contraction alkalosis)
* Persistently low chloride can contribute to poor growth
* Preferentially utilize KCl to help correct chloride rather than NaCl
* Additional Na when Na is normal may lead to Na and fluid retention
* Monitor K to ensure it is within normal range

<a id='9c30efe3-0350-4e01-987c-ff058ee4ea6e'></a>

<::logo: Stanford Children's Health / Lucile Packard Children's Hospital Stanford
Stanford Children's Health
Lucile Packard Children's Hospital Stanford
A red shield-like emblem with a stylized figure of a person is positioned to the left of the text, which is in red and gray, separated by a vertical gray line.::>

<a id='0172ca33-7485-4fa8-a27f-1ea7c41a15a8'></a>

<::logo: Stanford Medicine
Stanford MEDICINE
A dark red shield emblem featuring a tree, a book, and a caduceus symbol is placed to the left of the text "Stanford" in dark red, separated by a vertical line from "MEDICINE" in black.::>

<a id='c090bb7c-a175-49ea-8018-a605c4861fc4'></a>

# Hypophosphatemia

* IV phosphate is rarely given as a replacement (will often adjust electrolytes in TPN as much as possible)
* IV phosphate is given via sodium phosphate OR potassium phosphate
* Max rate of infusion: 0.06 mmol phosphate/kg/hour

<a id='d4222129-0c84-46f9-95b6-0cbface1025c'></a>

CAPTION ERROR

<a id='ee3654e9-ee92-465a-b87d-12ac759c6629'></a>

<::logo: Stanford Medicine
Stanford Medicine
A dark red shield emblem featuring a caduceus and other symbols is positioned to the left of the text "Stanford Medicine", which is separated by a vertical line.::>

<a id='c0785ff3-dec0-4aa7-bdfd-bf2f012269cf'></a>

GI Losses and Electrolytes

<a id='d8be7ab6-88ef-4754-a60e-dc5b17b40b6e'></a>

Replacement Fluids for Upper GI Losses
<table id="18-1">
<tr><td id="18-2"></td><td id="18-3"></td><td id="18-4" colspan="4">mEq/L</td></tr>
<tr><td id="18-5">Body Fluid Type</td><td id="18-6">Volume (mL/day)</td><td id="18-7">Na</td><td id="18-8">Cl</td><td id="18-9">K</td><td id="18-a">HCO₃ (yellow background)</td></tr>
<tr><td id="18-b">Saliva</td><td id="18-c">1000-1500</td><td id="18-d">10</td><td id="18-e">10</td><td id="18-f">26</td><td id="18-g">0 (blue background)</td></tr>
<tr><td id="18-h">Stomach/NG (↑acid)</td><td id="18-i">1000-9000</td><td id="18-j">20</td><td id="18-k">120</td><td id="18-l">10</td><td id="18-m">0</td></tr>
<tr><td id="18-n">Stomach/NG (↓acid)</td><td id="18-o">1000-2500</td><td id="18-p">80</td><td id="18-q">90</td><td id="18-r">15</td><td id="18-s">0</td></tr>
</table>

<a id='3cb6ac72-6df7-434d-9474-7dddf1379aeb'></a>

# Replacement Fluids for Lower GI Losses
<table id="18-t">
<tr><td id="18-u"></td><td id="18-v"></td><td id="18-w" colspan="4">mEq/L</td></tr>
<tr><td id="18-x">Body Fluid Type</td><td id="18-y">Volume (mL/day)</td><td id="18-z">Na</td><td id="18-A">Cl</td><td id="18-B">K</td><td id="18-C">HCO3</td></tr>
<tr><td id="18-D">Duodenum</td><td id="18-E">Variable</td><td id="18-F">140</td><td id="18-G">80</td><td id="18-H">5</td><td id="18-I">0</td></tr>
<tr><td id="18-J">Pancreas</td><td id="18-K">Variable</td><td id="18-L">140</td><td id="18-M">75</td><td id="18-N">5</td><td id="18-O">115</td></tr>
<tr><td id="18-P">Bile</td><td id="18-Q">Variable</td><td id="18-R">145</td><td id="18-S">100</td><td id="18-T">5</td><td id="18-U">35</td></tr>
<tr><td id="18-V">Ileum</td><td id="18-W">3000</td><td id="18-X">140</td><td id="18-Y">104</td><td id="18-Z">5</td><td id="18-10">30</td></tr>
<tr><td id="18-11">Colon</td><td id="18-12">Variable</td><td id="18-13">60</td><td id="18-14">40</td><td id="18-15">30</td><td id="18-16">0</td></tr>
</table>

<a id='5accb218-f403-4af0-aef5-843ca6325bdc'></a>

<::logo: Stanford Children's Health / Lucile Packard Children's Hospital Stanford
Stanford Children's Health
Lucile Packard Children's Hospital Stanford
A red shield-like emblem with a stylized figure inside, accompanied by text in red and gray.::>

<a id='bd308770-b68e-4eaf-a121-017f3b07f88f'></a>

<::logo: Stanford Medicine
Stanford MEDICINE
A dark red shield with a caduceus and a tree symbol, followed by "Stanford" in dark red, a vertical dark line, and "MEDICINE" in dark gray.::>

<a id='d614a67e-4c9c-4038-83e4-00f5fcf9cd1c'></a>

Metabolic Complications of PN

* Hyperglycemia/hypoglycemia
* Parenteral nutrition associated liver disease (PNALD):
  hepatic steatosis, TPN-associated cholestasis
* Refeeding syndrome
* Electrolyte imbalances
* Metabolic bone deficiency (imbalanced ratio of
  calcium and phosphorous)

<a id='13bce553-c3af-4dec-947e-4bfcce00dda8'></a>

<::logo: Stanford Children's Health, Lucile Packard Children's Hospital Stanford
Stanford Children's Health
Lucile Packard Children's Hospital Stanford
The logo features a red shield-like emblem with a stylized figure of a child.::>

<a id='49e33367-9dc2-4ba7-a68c-f034cb1002b6'></a>

<::logo: Stanford Medicine
Stanford MEDICINE
A maroon shield with a white caduceus and tree symbol is positioned to the left of the words "Stanford" in maroon and "MEDICINE" in black, separated by a vertical maroon line.::>

<a id='fce36221-71ea-435c-872f-fcbf06718b25'></a>

Medication Resources

<a id='798d4bca-6eb7-432b-b2a2-ba9aa2eb85bc'></a>

<table id="20-1">
<tr><td id="20-2"></td><td id="20-3">Resource</td><td id="20-4">Alternative Resource</td></tr>
<tr><td id="20-5">LPCH-specific medication dosing and administration</td><td id="20-6">Lexicomp LPCH Housestaff Manual (HSM)</td><td id="20-7"></td></tr>
<tr><td id="20-8">TPN compatibilities</td><td id="20-9">Search “TPN” in Lexicomp → select “Parenteral Nutrition (PN) – formerly TPN" under LPCH HSM → scroll to compatibility chart</td><td id="20-a">Trissel's Parenteral Compability via Micromedex or Lexi-comp</td></tr>
<tr><td id="20-b">Y-site compatibilities</td><td id="20-c">Trissel's Parenteral Compability via Micromedex or Lexi-comp</td><td id="20-d"></td></tr>
<tr><td id="20-e">General dosing and information</td><td id="20-f">Pediatric and Neonatal Lexi-Drugs</td><td id="20-g">NeoFax (Micromedex)</td></tr>
<tr><td id="20-h">Drug Policies</td><td id="20-i">LPCH Intranet</td><td id="20-j"></td></tr>
<tr><td id="20-k">Medication questions</td><td id="20-l">Pharmacists are available 24/7 • Search “Pharmacy” in Lexicomp→ select "Pharmacy Department” for list of phone # for all RX areas</td><td id="20-m">Emergencies: “LCPH Code Pharmacist" on voalte</td></tr>
</table>

<a id='539518e7-b1dc-4d83-9936-3b259926dec6'></a>

<::logo: Stanford Children's Health / Lucile Packard Children's Hospital Stanford
Stanford Children's Health
Lucile Packard Children's Hospital Stanford
A red shield-like emblem with a stylized figure inside, accompanied by text in red and gray.::>

<a id='4d0e354c-8577-4a22-88da-c3872a293788'></a>

<::logo: Stanford Medicine
Stanford MEDICINE
A maroon shield with a caduceus-like symbol and a cross, next to the text "Stanford" in maroon and "MEDICINE" in black, separated by a vertical maroon line.::>